Abstract
Monoclonal antibodies that effectively neutralize HIV-1 have been widely sought, yet few have been isolated. Now, technological advances in sera evaluation, B cell stimulation, microneutralization, and antibody cloning have allowed Burton and colleagues to identify two broadly neutralizing monoclonal antibodies, PG9 and PG16, which provide insights for HIV vaccine design.
MeSH terms
-
Antibodies, Monoclonal / immunology*
-
Antibodies, Monoclonal / isolation & purification
-
Antibodies, Neutralizing / immunology*
-
Antibodies, Neutralizing / isolation & purification
-
B-Lymphocytes / immunology*
-
HIV Antibodies / immunology*
-
HIV Antibodies / isolation & purification
-
HIV-1 / immunology*
-
Humans
-
Models, Biological
Substances
-
Antibodies, Monoclonal
-
Antibodies, Neutralizing
-
HIV Antibodies